GlaxoSmithKline's Board Backs CEO Walmsley After Elliott's Letter For Management ShakeupBenzinga • 07/02/21
ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing HigherInvestorPlace • 07/02/21
GlaxoSmithKline backs under fire CEO and adds Parkinson's and Alzheimer's drugs to portfolioProactive Investors • 07/02/21
Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseasesGlobeNewsWire • 07/02/21
GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value'Market Watch • 07/02/21
Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For 'Years Of Under Management'Benzinga • 07/01/21
GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should KnowThe Motley Fool • 07/01/21
GlaxoSmithKline called for top management review by activist investor Elliott ManagementProactive Investors • 07/01/21
TUMS® Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, with Hot Food Expert Sean EvansPRNewsWire • 06/29/21
GlaxoSmithKline taps Goldman, Citi to advise on consumer unit spinoff - Bloomberg NewsReuters • 06/25/21